The conference brought together patients and patient advocates with pharmaceutical industry professionals, hospital leaders, and technology experts to explore how emerging technologies such as AI, machine learning, virtual reality, and social media can be strategically leveraged to enhance patient engagement, education, and support. Participants will learn about the latest advancements in these technologies, showcase successful case studies, and discuss strategies for addressing trust, privacy, health equity, and regulatory compliance challenges. The conference aims to foster collaboration, knowledge-sharing, and networking among attendees to develop innovative, patient-centric solutions while examining the ethical implications and guidelines for responsible implementation of these technologies in healthcare. By the end of the conference, participants will be equipped with the knowledge and skills necessary to effectively leverage emerging technologies in their patient-centric initiatives, improving outcomes and experiences while navigating the policy and regulatory landscape.

Visit this page to see the full conference program and view the recordings using the links below.

See photos of this event and a summary of the highlights on this LinkedIn Post.

Register to DCI Network here to be alerted of new content and future events.

Description

Welcome Remarks:

Dr. Yuri Quintana, PhD, Chief, Division of Clinical Informatics, Department of Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School

Dr. Mark Zeidel, MD, Chief, Department of Medicine, Beth Israel Deaconess Medical Center

Dr. Charles Safran, MD, Professor Emeritus, Harvard Medical School

Description

Panel 2: Innovative Healthcare Delivery

Bridging the Gaps: Leveraging AI to Ensure Continuity of Care from Hospital to Home

Dr. Amy Price, DPhil, Senior Research Scientist, Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine, Dartmouth College; BMJ Research Editor (Patient and Public Partnership)

Description

Panel 3: Future of Chatbots and Ambient AI

Designing and Testing an Evidence-Based Mental Health Chatbot using Generative Artificial Intelligence

Dr. Nicholas C. Jacobson, PhD, Assistant Professor, Biomedical Data Science and Psychiatry, Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College

Description

Panel 4: Future Approaches to Patient Engagement and Medication Information Access

FDA Digital Initiatives for Medication Information

Dr. Gideon Scott Gordon, PhD, Senior Health Informatics Officer, Office of Strategic Programs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration